title: Cinacalcet in the treatment of hypercalcaemia and control of hyperparathyroidism due to ectopic parathyroid glands.
authors.forename: M
authors.initials: M
authors.lastname: Picazo Sánchez
authors.forename: M
authors.initials: M
authors.lastname: Cuxart Pérez
authors.forename: R
authors.initials: R
authors.lastname: Sans Lorman
authors.forename: C
authors.initials: C
authors.lastname: Sardà Borroy
mesh_terms: D000369:Aged, 80 and over; D057966:Calcimimetic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002117:Calcitriol / Q000627:therapeutic use; D002828:Choristoma / Q000150:complications* / Q000000981:diagnostic imaging; D000069449:Cinacalcet; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D006961:Hyperparathyroidism / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000209:etiology; D008477:Mediastinal Diseases / Q000188:drug therapy*; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010280:Parathyroid Glands / Q000000981:diagnostic imaging / Q000378:metabolism; D010281:Parathyroid Hormone / Q000378:metabolism; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi
chemical_list: D057966:Calcimimetic Agents; D009281:Naphthalenes; D010281:Parathyroid Hormone; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D002117:Calcitriol; D000069449:Cinacalcet